Potassium inhibits dietary salt-induced transforming growth factor-β production

Hypertension

Volumn 54, Issue 5, 2009, Pages 1159-1163

  Ying, Wei Zhong ^a,b   Aaron, Kristal ^a,b   Wang, Pei Xuan ^a,b   Sanders, Paul W ^a,b,c,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Aorta; Dietary sodium chloride; Endothelium; Iberiotoxin; Physiology; Potassium channel

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; IBERIOTOXIN; POTASSIUM; SODIUM CHLORIDE; TETRYLAMMONIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ALPHA CHAIN; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SALT INTAKE; SODIUM RESTRICTION; VASCULAR RING; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; HYPERTENSION; METABOLISM; PATHOLOGY; PROBABILITY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; POTASSIUM; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; SODIUM CHLORIDE, DIETARY; TRANSFORMING GROWTH FACTOR BETA;

EID: 70449723265     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.138255     Document Type: Article

References (33)

1. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734-1737.
2. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37:429-432.
3. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885.
4. Meneely GR, Ball CO. Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am J Med. 1958;25:713-725.
5. Yu HCM, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation. 1998;98:2621-2628.
6. Sanders PW, Gibbs CL, Akhi KM, MacMillan-Crow LA, Zinn KR, Chen Y-F, Young CJ, Thompson JA. Increased dietary salt accelerates chronic allograft nephropathy in rats. Kidney Int. 2001;59:1149-1157.
7. Benstein JA, Feiner HD, Parker M, Dworkin LD. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol. 1990;258(6 pt 2):F1675-F1681.
8. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension. 2005;46:308-312.
9. Ying W-Z, Sanders PW. Dietary salt modulates renal production of transforming growth factor-/3 in rats. Am J Physiol. 1998;274(4 pt 2):F635-F641.
10. Ying W-Z, Sanders PW. Dietary salt increases endothelial nitric oxide synthase and TGF-/31 in rat aortic endothelium. AmJ Physiol. 1999;277(4 pt 2):H1293-H1298.
11. Ying W-Z, Sanders PW. Increased dietary salt activates rat aortic endothelium. Hypertension. 2002;39:239-244.
12. Ying W-Z, Sanders PW. Dietary salt intake activates MAP kinases in the rat kidney. FASEB J. 2002;16:1683-1684.
13. Ying W-Z, Sanders PW. The interrelationship between TGF-/31 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol. 2003;285:F902-F908.
14. Ying WZ, Aaron K, Sanders PW. Mechanism of dietary salt-mediated increase in intravascular production of TGF-/31. Am J Physiol Renal Physiol. 2008;295:F406-F414.
15. Ying W-Z, Sanders PW. Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-/31. Am J Physiol. 1998;275(1 pt 2):F18-F24.
16. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994;216:276-284.
17. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, Garcia ML. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990;265:11083-11090.
18. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev. 2001;81:1415-1459.
19. Knaus HG, Eberhart A, Koch RO, Munujos P, Schmalhofer WA, Warmke JW, Kaczorowski GJ, Garcia ML. Characterization of tissue-expressed alpha subunits of the high conductance Ca(2 + )-activated K + channel. J Biol Chem. 1995;270:22434-22439.
20. Lu R, Alioua A, Kumar Y, Eghbali M, Stefani E, Toro L. MaxiK channel partners: physiological impact. J Physiol. 2006;570:65-72.
21. Cui J, Yang H, Lee US. Molecular mechanisms of BK channel activation. Cell Mol Life Sci. 2009;66:852-875.
22. Navarro-Antolin J, Levitsky KL, Calderon E, Ordonez A, Lopez-Barneo J. Decreased expression of maxi-K+ channel beta1-subunit and altered vasoregulation in hypoxia. Circulation. 2005;112:1309-1315.
23. Woda CB, Bragin A, Kleyman TR, Satlin LM. Flow-dependent K + secretion in the cortical collecting duct is mediated by a maxi-K channel. Am J Physiol Renal Physiol. 2001;280:F786-F793.
24. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production: modulation by potassium channel blockade. J Clin Invest. 1995;95: 1363-1369.
25. Meneely GR, Tucker RG, Darby WJ, Auerbach SH. Chronic sodium chloride toxicity: hypertension, renal and vascular lesions. Ann Intern Med. 1953;39:991-998.
26. Meneely GR, Ball CO, Youmans JB. Chronic sodium chloride toxicity: the protective effect of added potassium chloride. Ann Intern Med. 1957; 47:263-273.
27. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention Follow-Up Study. Arch Intern Med. 2009;169:32-40.
28. Owens GK, Geisterfer AA, Yang YW, Komoriya A. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988;107:771-780.
29. Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem. 1987;262:6443-6446.
30. Mozes MM, Bottinger EP, Jacot TA, Kopp JB. Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol. 1999;10:271-280.
31. Zacchigna L, Vecchione C, Notte A, Cordenonsi M, Dupont S, Maretto S, Cifelli G, Ferrari A, Maffei A, Fabbro C, Braghetta P, Marino G, Selvetella G, Aretini A, Colonnese C, Bettarini U, Russo G, Soligo S, Adorno M, Bonaldo P, Volpin D, Piccolo S, Lembo G, Bressan GM. Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell. 2006;124:929-942.
32. Tamaki K, Okuda S, Nakayama M, Yanagida T, Fujishima M. Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats. J Am Soc Nephrol. 1996;7:2578-2589.
33. Tobian L. Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals. Am J Clin Nutr. 1997;65:606S-611S